This work is licensed under a Creative Commons Attribution 4.0 International License.
BP105
General Information
DRACP ID DRACP00471
Peptide Name BP105
Sequence LKLFKKILKYL
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cell-penetrating peptides
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| CAPAN-1 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50=22.7 ± 1.5 µM | MTT assay | 48 h | 1 |
| MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=29.2 ± 4.2 µM | MTT assay | 48 h | 1 |
Hemolytic Activity Human erythrocytes: 39.0 ± 8.5% Hemolysis=150 µM
Normal (non-cancerous) Cytotoxicity NIH 3T3: IC50=39.0 ± 8.5 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C72H123N15O13
Absent amino acids ACDEGHMNPQRSTVW
Common amino acids KL
Mass 158542
Pl 10.87
Basic residues 4
Acidic residues 0
Hydrophobic residues 6
Net charge 4
Boman Index 524
Hydrophobicity 50.91
Aliphatic Index 177.27
Half Life
Mammalian: 5.5 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 1490
Absorbance 280nm 149
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 24480922
Title Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties
Year 2014
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_4987
This work is licensed under a Creative Commons Attribution 4.0 International License.